Amalgent Therapeutics

Greenville, United States

Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.

Feb 2023

Debt Financing

Biotechnology Health Care Medical Pharmaceutical Therapeutics

Top Investors

North Carolina Biotechnology Center

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amalgent Therapeutics

Who are Amalgent Therapeutics's investors?

Amalgent Therapeutics's investors include North Carolina Biotechnology Center.

Where is Amalgent Therapeutics headquartered?

Amalgent Therapeutics is headquartered in Greenville, United States.

What does Amalgent Therapeutics do?

Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.

What stage is Amalgent Therapeutics at?

Amalgent Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 16, 2023.

MLA

"Amalgent Therapeutics — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/amalgent-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Amalgent Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/amalgent-therapeutics

Wikipedia (cite web)

{{cite web |title=Amalgent Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amalgent-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 16, 2023.